Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,325 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00109356 | Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia | unknown | Phase 1 / Phase 2 | 55 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00146913 | AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year | unknown | Phase 2 | 30 | Hospices Civils de LyonOTHER | 1 | Apr 27, 2007 |
| NCT00149136 | Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. | unknown | Phase 2 | 30 | Hospices Civils de LyonOTHER | 1 | Apr 27, 2007 | clinicaltrials |
| NCT00169598 | Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study(TEPELY) | unknown | N/A | 80 | Hospices Civils de LyonOTHER | 1 | Apr 27, 2007 | clinicaltrials |
| NCT00466284 | Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 | 46 | Grupo Gallego de Cancer de PulmonOTHER | 1 | Apr 27, 2007 | clinicaltrials |
| NCT00463359 | A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base | unknown | N/A | 50 | University of GlasgowOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00160836 | Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter | unknown | Phase 1 | 68 | University Hospital, GenevaOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00462189 | Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease | unknown | Phase 1 | 40 | Cambridge Antibody TechnologyOTHER | 3 | Apr 18, 2007 | clinicaltrials |
| NCT00457860 | Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease | unknown | Phase 1 | 50 | Cambridge Antibody TechnologyOTHER | 2 | Apr 17, 2007 | clinicaltrials |
| NCT00460447 | Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation | unknown | Phase 1 / Phase 2 | 30 | University Hospital Carl Gustav CarusOTHER | 1 | Apr 16, 2007 | clinicaltrials |
| NCT00192829 | Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma | unknown | — | 100 | Rambam Health Care CampusOTHER | 1 | Apr 11, 2007 | clinicaltrials |
| NCT00215722 | XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | 45 | Grupo de Investigacao do Cancro DigestivoOTHER | 1 | Apr 6, 2007 | clinicaltrials |
| NCT00455286 | a Phase II Study in Primary Central Nervous System Lymphoma | unknown | Phase 2 | 25 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 4, 2007 | clinicaltrials |
| NCT00157274 | Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome | unknown | Phase 2 | 20 | Latin American Cooperative Onco-Haematology Group - PeruOTHER | 1 | Apr 3, 2007 | clinicaltrials |
| NCT00154440 | Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation | unknown | Phase 3 | 200 | Technische Universität DresdenOTHER | 1 | Mar 26, 2007 | clinicaltrials |
| NCT00155103 | Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma | unknown | — | 1,600 | National Taiwan University HospitalOTHER | 1 | Mar 21, 2007 | clinicaltrials |
| NCT00438581 | Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma(Zevalin) | unknown | Phase 2 | 40 | McGill UniversityOTHER | 1 | Feb 27, 2007 | clinicaltrials |
| NCT00426062 | Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva | unknown | — | — | Sheba Medical CenterOTHER_GOV | 1 | Feb 21, 2007 | clinicaltrials |
| NCT00435955 | Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma | unknown | Phase 3 | 240 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Feb 16, 2007 | clinicaltrials |
| NCT00400894 | Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma | unknown | — | 750 | ProteoSys AGINDUSTRY | 0 | Feb 5, 2007 | clinicaltrials |
| NCT00429065 | Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old. | unknown | — | 30 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Jan 31, 2007 | clinicaltrials |
| NCT00425022 | VATS Lobectomy for Clinical Stage IB or II Lung Cancer | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 30, 2007 | clinicaltrials |
| NCT00327314 | Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma | unknown | Phase 2 | 100 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Dec 28, 2006 | clinicaltrials |
| NCT00062907 | Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer | unknown | Phase 1 | 9 | Corixa CorporationINDUSTRY | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00406900 | Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma | unknown | — | 560 | Ludwig-Maximilians - University of MunichOTHER | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00402090 | DHPLC Determination of TPMT Polymorphisms. | unknown | — | 160 | National Institute of CancerologíaOTHER_GOV | 1 | Nov 22, 2006 | clinicaltrials |
| NCT00048464 | T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant | unknown | Phase 1 / Phase 2 | 35 | Xcyte TherapiesINDUSTRY | 1 | Nov 7, 2006 | clinicaltrials |
| NCT00090727 | Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | unknown | Phase 1 | 45 | NovaceaINDUSTRY | 1 | Nov 2, 2006 | clinicaltrials |
| NCT00168883 | Study for Patients With Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 80 | Charite University, Berlin, GermanyOTHER | 1 | Nov 1, 2006 | clinicaltrials |
| NCT00392548 | URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol | unknown | — | 130 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Oct 26, 2006 | clinicaltrials |
| NCT00261612 | Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma | unknown | Phase 2 | 16 | Medical University of ViennaOTHER | 1 | Oct 18, 2006 | clinicaltrials |
| NCT00294476 | IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma | unknown | Phase 2 | 30 | GammaCanINDUSTRY | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00164086 | Atorvastatin in Myeloma | unknown | Phase 1 | — | Bayside HealthOTHER_GOV | 1 | Oct 11, 2006 | clinicaltrials |
| NCT00297557 | Dual Time Point PET Imaging in Lymphoma | unknown | — | — | Royal Marsden NHS Foundation TrustOTHER | 0 | Oct 11, 2006 | clinicaltrials |
| NCT00384553 | Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma | unknown | Phase 1 / Phase 2 | 30 | University of MagdeburgOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00385125 | Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL | unknown | Phase 2 | 30 | University of MagdeburgOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00163930 | Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata | unknown | — | — | Bayside HealthOTHER_GOV | 1 | Oct 3, 2006 | clinicaltrials |
| NCT00382694 | Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients | unknown | Phase 2 | 80 | Nordic Myeloma Study GroupOTHER | 1 | Sep 29, 2006 | clinicaltrials |
| NCT00146276 | Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer | unknown | Phase 3 | 178 | Association of Urologic Oncology (AUO)OTHER | 1 | Sep 27, 2006 | clinicaltrials |
| NCT00333008 | A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status. | unknown | Phase 2 | 27 | The Alvin and Lois Lapidus Cancer InstituteOTHER | 1 | Sep 26, 2006 | clinicaltrials |
| NCT00378755 | Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM | unknown | Phase 2 | 62 | Korean Multiple Myeloma Working PartyOTHER | 1 | Sep 22, 2006 | clinicaltrials |
| NCT00180882 | LMBA02 Protocol for Patients With a Burkitt Lymphoma | unknown | Phase 3 | 260 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00126269 | Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary | unknown | Phase 3 | 192 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00127049 | Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors | unknown | Phase 2 | 37 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | unknown | Phase 2 | 210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00311857 | Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) | unknown | Phase 1 / Phase 2 | 46 | Heidelberg UniversityOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00300001 | Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes | unknown | — | 300 | Community Cancer CareOTHER | 1 | Aug 25, 2006 | clinicaltrials |
| NCT00231712 | Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant | unknown | — | 50 | Julius-Maximilians UniversityOTHER | 1 | Aug 23, 2006 | clinicaltrials |
| NCT00364663 | The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Aug 16, 2006 | clinicaltrials |
Data updated 23 days agoSource updated May 7, 2007source: clinicaltrials